BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32208384)

  • 1. Cardiovascular response to small-molecule APJ activation.
    Ason B; Chen Y; Guo Q; Hoagland KM; Chui RW; Fielden M; Sutherland W; Chen R; Zhang Y; Mihardja S; Ma X; Li X; Sun Y; Liu D; Nguyen K; Wang J; Li N; Rajamani S; Qu Y; Gao B; Boden A; Chintalgattu V; Turk JR; Chan J; Hu LA; Dransfield P; Houze J; Wong J; Ma J; Pattaropong V; Véniant MM; Vargas HM; Swaminath G; Khakoo AY
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32208384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
    Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
    Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists.
    Tora G; Jiang J; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux C; Xu C; Galella MA; Wang T; He Y; Wexler RR; Finlay HJ
    Bioorg Med Chem Lett; 2021 Oct; 50():128325. PubMed ID: 34403724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate.
    Johnson JA; Kim SH; Jiang J; Phillips M; Schumacher WA; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux C; He Y; Chen XQ; Xu C; Galella MA; Wang T; Gordon DA; Wexler RR; Finlay HJ
    J Med Chem; 2021 Mar; 64(6):3086-3099. PubMed ID: 33689340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gαi-biased apelin analog protects against isoproterenol-induced myocardial dysfunction in rats.
    Coquerel D; Delile E; Dumont L; Chagnon F; Murza A; Sainsily X; Salvail D; Sarret P; Marsault E; Auger-Messier M; Lesur O
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1646-H1656. PubMed ID: 33635165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ.
    Myers MC; Bilder DM; Cavallaro CL; Chao HJ; Su S; Burford NT; Nayeem A; Wang T; Yan M; Langish RA; Dabros M; Li YX; Rose AV; Behnia K; Onorato JM; Gargalovic PS; Wexler RR; Lawrence RM
    Bioorg Med Chem Lett; 2020 Apr; 30(7):126955. PubMed ID: 32035698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure.
    Pang H; Han B; Yu T; Zong Z
    Int J Mol Med; 2014 Sep; 34(3):756-64. PubMed ID: 24993609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure.
    Barnes GD; Alam S; Carter G; Pedersen CM; Lee KM; Hubbard TJ; Veitch S; Jeong H; White A; Cruden NL; Huson L; Japp AG; Newby DE
    Circ Heart Fail; 2013 May; 6(3):482-91. PubMed ID: 23519586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation.
    Reed AB; Lanman BA; Holder JR; Yang BH; Ma J; Humphreys SC; Wang Z; Chan JCY; Miranda LP; Swaminath G; Allen JG
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127499. PubMed ID: 32858124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure.
    Koguchi W; Kobayashi N; Takeshima H; Ishikawa M; Sugiyama F; Ishimitsu T
    Circ J; 2012; 76(1):137-44. PubMed ID: 22082814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenyl Acid Derivatives as APJ Receptor Agonists.
    Su S; Clarke A; Han Y; Chao HJ; Bostwick J; Schumacher W; Wang T; Yan M; Hsu MY; Simmons E; Luk C; Xu C; Dabros M; Galella M; Onorato J; Gordon D; Wexler R; Gargalovic PS; Lawrence RM
    J Med Chem; 2019 Nov; 62(22):10456-10465. PubMed ID: 31724863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression.
    Atluri P; Morine KJ; Liao GP; Panlilio CM; Berry MF; Hsu VM; Hiesinger W; Cohen JE; Joseph Woo Y
    Cell Mol Biol Lett; 2007; 12(1):127-38. PubMed ID: 17119870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and preparation of N-linked hydroxypyridine-based APJ agonists.
    Richter JM; Alex Bates J; Gargalovic P; Onorato JM; Generaux C; Wang T; Gordon DA; Wexler RR; Finlay HJ
    Bioorg Med Chem Lett; 2022 Oct; 73():128882. PubMed ID: 35817293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
    Japp AG; Newby DE
    Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
    Sato T; Kuba K
    Nihon Yakurigaku Zasshi; 2019; 153(4):172-178. PubMed ID: 30971657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin protects heart against ischemia/reperfusion injury in rat.
    Zeng XJ; Zhang LK; Wang HX; Lu LQ; Ma LQ; Tang CS
    Peptides; 2009 Jun; 30(6):1144-52. PubMed ID: 19463748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of apelin in central cardiovascular regulation in rats with post-infarct heart failure maintained on a normal fat or high fat diet.
    Czarzasta K; Cudnoch-Jedrzejewska A; Szczepanska-Sadowska E; Fus L; Puchalska L; Gondek A; Dobruch J; Gomolka R; Wrzesien R; Zera T; Gornicka B; Kuch M
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):983-94. PubMed ID: 27378063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
    Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
    Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling.
    Galon-Tilleman H; Yang H; Bednarek MA; Spurlock SM; Paavola KJ; Ko B; To C; Luo J; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
    J Biol Chem; 2017 Feb; 292(5):1925-1933. PubMed ID: 27994053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.